By stratifying the somatic mutations by clinical tumor subgroup, ductal BCs displayed mostly TP53 and PIK3CA mutations, lobular tumors displayed CDH1 and PIK3CA mutations, and approximately 90% of medullary BCs harbored TP53 mutations [93]. Here, CDH1 is linked to neoplasm.